This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event from December 12 - 16, 2021
Live In-Person Experience Delivered December 12 - 16 2021Marriott Marquis San Diego

Laura Walker, Ph.D
Senior Director of Antibody Sciences at Adimab, LLC.


Laura M. Walker is the Sr. Director of Antibody Sciences at Adimab and the Chief Scientific Officer at Adagio Therapeutics, Inc. Her team at Adimab is focused on understanding human B cell responses to viral infection and discovering broadly cross-reactive neutralizing antibodies to a wide variety of emerging viral pathogens, including Ebola, Zika, yellow fever, and SARS-CoV-2. At Adagio Therapeutics, Laura oversees a broad portfolio of research in the area of viral immunology, including the identification of potent neutralizing antibodies to advance into clinical development. Prior to joining Adimab in 2012, Laura earned her Ph.D. in Immunology and Microbiology at The Scripps Research Institute and completed a post-doctoral research fellowship in Immunology at The University of California-San Francisco.

Agenda Sessions

  • Jim Huston Science Talent Award Winner Presentation: Broadly Neutralizing Antibodies to Combat Antigenically Diverse Viruses

  • Tackling SARS-CoV-2 and Future Sarbecovirus Threats with Broadly Neutralizing Antibodies